Machine Learning in Electroconvulsive Therapy: A Systematic Review.

Journal: The journal of ECT
Published Date:

Abstract

Despite years of research, we are still not able to reliably predict who might benefit from electroconvulsive therapy (ECT) treatment. As we exhaust what is possible using traditional statistical analysis, ECT remains a good candidate for machine learning approaches due to the large data sets with data captured through electroencephalography (EEG) and other objective measures. A systematic review of 6 databases led to the full-text examination of 26 articles using machine learning approaches in examining data predicting response to ECT treatment. The identified articles used a wide variety of data types covering structural and functional imaging data (n = 15), clinical data (n = 5), a combination of clinical and imaging data (n = 2), EEG (n = 3), and social media posts (n = 1). The clinical indications in which response prediction was assessed were depression (n = 21) and psychosis (n = 4). Changes in multiple anatomical regions in the brain were identified as holding a predictive value for response to ECT. These primarily centered on the limbic system and associated networks. Clinical features predicting good response to ECT in depression included shorter duration, lower severity, higher medication dose, psychotic features, low cortisol levels, and positive family history. It has also been possible to predict the likelihood of relapse of readmission with psychosis after ECT treatment, including a better response if higher transfer entropy was calculated from EEG signals. A transdisciplinary approach with an international consortium collecting a wide range of retrospective and prospective data may help to refine and extend these outcomes and translate them into clinical practice.

Authors

  • Robert M Lundin
    From the Barwon Health MHDAS, Change to Improve Mental Health (CHIME), University Hospital Geelong, Geelong, Victoria, Australia.
  • Veronica Podence Falcao
    Hospital Beatriz Ângelo, Lisbon, Portugal.
  • Savani Kannangara
    University of Auckland, Auckland, New Zealand.
  • Charles W Eakin
    From the Mental Health, Drug and Alcohol Services, Barwon Health.
  • Moloud Abdar
    Département d'Informatique, Université du Québec à Montréal, Montréal, QC, Canada. m.abdar1987@gmail.com.
  • John O'Neill
    Department of Urology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Abbas Khosravi
  • Harris Eyre
  • Saeid Nahavandi
  • Colleen Loo
  • Michael Berk
    IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia.